Status:

COMPLETED

Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic Rickets

Lead Sponsor:

Yale University

Collaborating Sponsors:

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Conditions:

Hypophosphatemia, Familial

Hyperparathyroidism

Eligibility:

All Genders

9+ years

Phase:

PHASE3

Brief Summary

The purpose of this study is to determine the effectiveness of paricalcitol, a form of synthetic vitamin D, in lowering parathyroid hormone (PTH) levels and reducing disease symptoms in children and a...

Detailed Description

XLH rickets is a rare inherited disorder in which the bones become painfully soft and bend easily because of a phosphate deficiency. This genetic defect causes the kidneys to allow excretion of an ina...

Eligibility Criteria

Inclusion

  • Diagnosis of XLH rickets
  • Fasting serum calcium of 10.7 mg/dl or less
  • Fasting PTH greater than 40 nleq/ml and less than 120 nleq/ml in the mid-molecule PTH assay at screening (upper limit of normal is 25 nleq/ml)
  • Willing and able to participate in the trial
  • Taking stable dose of standard therapy for XLH rickets for at least 2 months prior to study entry
  • Concomitant therapy for XLH rickets will not be an exclusion criteria
  • Parent or guardian willing to provide informed consent, if applicable

Exclusion

  • Concomitant kidney failure (estimated creatinine clearance less than 60 cc/min or serum creatinine greater than 1.5 mg/dl)
  • Serum 25-hydroxy vitamin D less than 20 ng/ml. Participants meeting this criterion will receive vitamin D3 supplementation for 3 months and then be rescreened.
  • Unable to comply with protocol and appropriate follow-up visits
  • Treatment with agents that may affect skeletal metabolism, such as glucocorticoids and anticonvulsants

Key Trial Info

Start Date :

January 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2012

Estimated Enrollment :

33 Patients enrolled

Trial Details

Trial ID

NCT00417612

Start Date

January 1 2007

End Date

August 1 2012

Last Update

March 17 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Yale University School of Medicine

New Haven, Connecticut, United States, 06520